Bryan C. BARNHART
13Patents
4h-index
39Co-inventors
52Inventor score
Filing activity: Nov 19, 2015 → Mar 15, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9605080B2 | Antibodies against CD73 | Physics | 19 | Active |
| US10100129B2 | Antibodies against CD73 and uses thereof | Physics | 13 | Active |
| US10653791B2 | Antibodies comprising modified heavy constant regions | Chemistry; Metallurgy | 7 | Active |
| US11213586B2 | Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) | Chemistry; Metallurgy | 4 | Active |
| US10167343B2 | Antibodies against CD73 | Physics | 3 | Active |
| US10479838B2 | Antibodies to CD40 with enhanced agonist activity | Chemistry; Metallurgy | 2 | Active |
| US11306149B2 | Anti-CD40 antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10584160B2 | Glypican-3-binding fibronectin based scaffold molecules | Chemistry; Metallurgy | 1 | Active |
| US10844130B2 | Nucleic acids encoding an anti-CD40 antibody | Chemistry; Metallurgy | 0 | Active |
| US11352440B2 | Antibodies against CD73 and uses thereof | Physics | 0 | Active |
| US11952427B2 | Anti-CD40 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11103579B2 | Combination of DR5 agonist and anti-PD-1 antagonist and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11524992B2 | Glypican-3-binding fibronectin based scaffold molecules | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.